This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Althaus, C. L.
Right arrow Articles by Bonhoeffer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Althaus, C. L.
Right arrow Articles by Bonhoeffer, S.

 Previous Article  |  Next Article 

Journal of Virology, November 2005, p. 13572-13578, Vol. 79, No. 21
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.21.13572-13578.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Stochastic Interplay between Mutation and Recombination during the Acquisition of Drug Resistance Mutations in Human Immunodeficiency Virus Type 1

Christian L. Althaus{dagger} and Sebastian Bonhoeffer*

Ecology & Evolution, ETH Zürich, ETH Zentrum CHN, CH-8092 Zürich, Switzerland

Received 15 April 2005/ Accepted 4 August 2005

The emergence of drug resistance mutations in human immunodeficiency virus (HIV) has been a major setback in the treatment of infected patients. Besides the high mutation rate, recombination has been conjectured to have an important impact on the emergence of drug resistance. Population genetic theory suggests that in populations limited in size recombination may facilitate the acquisition of beneficial mutations. The viral population in an infected patient may indeed represent such a population limited in size, since current estimates of the effective population size range from 500 to 105. To address the effects of limited population size, we therefore expand a previously described deterministic population genetic model of HIV replication by incorporating the stochastic processes that occur in finite populations of infected cells. Using parameter estimates from the literature, we simulate the evolution of drug-resistant viral strains. The simulations show that recombination has only a minor effect on the rate of acquisition of drug resistance mutations in populations with effective population sizes as small as 1,000, since in these populations, viral strains typically fix beneficial mutations sequentially. However, for intermediate effective population sizes (104 to 105), recombination can accelerate the evolution of drug resistance by up to 25%. Furthermore, a reduction in population size caused by drug therapy can be overcome by a higher viral mutation rate, leading to a faster evolution of drug resistance.


* Corresponding author. Mailing address: Ecology & Evolution, ETH Zürich, ETH Zentrum CHN, CH-8092 Zürich, Switzerland. Phone: 41 1 632 7106. Fax: 41 1 632 12 71. E-mail: sebastian.bonhoeffer{at}env.ethz.ch.

{dagger} Present address: Theoretical Biology, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.


Journal of Virology, November 2005, p. 13572-13578, Vol. 79, No. 21
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.21.13572-13578.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Di Mascio, M., Srinivasula, S., Bhattacharjee, A., Cheng, L., Martiniova, L., Herscovitch, P., Lertora, J., Kiesewetter, D. (2009). Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography. Antimicrob. Agents Chemother. 53: 4086-4095 [Abstract] [Full Text]  
  • Onafuwa-Nuga, A., Telesnitsky, A. (2009). The Remarkable Frequency of Human Immunodeficiency Virus Type 1 Genetic Recombination. Microbiol. Mol. Biol. Rev. 73: 451-480 [Abstract] [Full Text]  
  • Codoner, F. M., Elena, S. F. (2008). The promiscuous evolutionary history of the family Bromoviridae. J. Gen. Virol. 89: 1739-1747 [Abstract] [Full Text]  
  • Vijay, N. N. V., Vasantika, , Ajmani, R., Perelson, A. S., Dixit, N. M. (2008). Recombination increases human immunodeficiency virus fitness, but not necessarily diversity. J. Gen. Virol. 89: 1467-1477 [Abstract] [Full Text]  
  • Nora, T., Charpentier, C., Tenaillon, O., Hoede, C., Clavel, F., Hance, A. J. (2007). Contribution of Recombination to the Evolution of Human Immunodeficiency Viruses Expressing Resistance to Antiretroviral Treatment. J. Virol. 81: 7620-7628 [Abstract] [Full Text]